Condition
Adjuvant Chemoradiotherapy clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Adjuvant Chemoradiotherapy clinical trials that are recruiting, in China. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Predicting post-surgery treatment for liver cancer using AI and whole-slide images
Aims to see if an AI model based on postoperative tissue images and imaging data can help decide if patients with hepatocellular carcinoma should receive adjuvant therapy after surgery.
-
Postoperative concurrent chemoradiotherapy with simultaneous integrated boost for intrahepatic cholangiocarcinoma
This treatment tests whether adding postoperative concurrent chemoradiotherapy with a simultaneous integrated boost plus oral capecitabine can reduce recurrence in adults after liver surgery for intrahepatic cholangiocarcinoma with narrow margins or positive lymph nodes.
Related topics
Quick answers
How many Adjuvant Chemoradiotherapy clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.